third quarter earn call name operator today call operator instruction conference record replay purpose begin would like remind discussion conference call include forward look statement factor could cause actual result differ materially discuss company recent file also discussion include certain financial measure reconciliation directly comparable financial measure find today press release exhibit current report form file today turn call chairman chief executive officer begin chairman chief executive officer thank welcome third quarter earn call join today vice president investor relation today call provide open comment follow update trend quarter provide additional detail regard quarterly result open call quarter post organic sale growth versus drive excellent double digit growth business offset softer sale knee spine resurgence slowdown deferrable procedure primarily impact worsen quarter implant business challenge strong result product technology capital product across portfolio addition strong performance emergent business include core trauma business another standout performance neurovascular international organic growth outpace growth represent robust performance lessen impact across major geography include strong result across emerge market year date organic growth continue uncertainty relate recovery healthcare staff shortage update full year organic sale growth guidance compare capital equipment order book remain strong position eventual procedure recovery adjust grow versus continue focus drive cash flow lead year date cash conversion growth although solid lower expectation reflect update guidance elaborate meanwhile please cash flow performance provide additional flexibility future opportunity quarter progress anticipate delta variant remain confident outlook business evidence strong international performance expect business continue perform high level uncertainty concentrate deferrable procedure unite state continue feel bullish longer term prospect pandemic recede prove strategy strong fundamental excite share upcoming analyst turn call vice president investor relation thank comment today focus provide additional insight current environment include certain product geography perform quarter addition provide update continue integration medical include performance combine trauma extremity business quarter significant spike delta variant drive increase infection hospitalization require higher hospital utilization ultimately lead deferral elective procedure addition increase hospitalization hospital staff shortage also pressure procedural volume throughout quarter primarily impact implant relate business include knee spine many case defer period time however disease state treat degenerative patient defer procedure eventually return procedure complete impact elective procedure unite state geography outside unite state within unite state area disruption state disruption widespread southeast southwest portion country impact major market like throughout quarter market around world include experience intermittent lockdown throughout quarter also drive uneven result across implant relate business market quarter impact previous quarter impressive organic growth compare relate hospitalization unite state begin trend upwards toward progressively worsen begin quarter infection hospitalization rate decline impact region continue result begin improvement impact business first week however expect recovery partially mute discontinue hospital staff challenge ongoing relate volatility assumption fourth quarter deferrable procedure gradually return start base return normal level quarter result expect fourth quarter growth rate deferrable business similar third quarter despite ongoing challenge elective procedure strong performance emerge business like neurovascular grow strong double digit compare result continue market expansion ongoing global demand innovative technology addition demand capital equipment remain healthy evidence continue strong sale performance robust order book small large capital product include surgical technology emergency care neurosurgical business ongoing strength capital also reflect continue demand robotic technology industry lead robot continue help surgeon improve patient outcome know trend across capital expect continue hospital take advantage flexible finance prioritize capital product like within portfolio critical provide emergency care drive profitable procedure ensure safe work environment caregiver patient turn medical integration continue progress region function unite state commercial integration move past sale force realignment focus continue business process improvement system efficiency also develop long term product pipeline strategy outside unite state continue work integration activity include sale force indirect channel alignment across geographic region overall remain please progress pace integration past year include medical combine trauma extremity business grow year date year date growth unite state drive strong double digit growth core trauma upper extremity business reflect execution sale integration unite state outside unite state sale decline year date drive time distributor conversion pacific decline legacy trauma business result provincial tender process consider latest result ongoing relate volatility provincial tender expect combine trauma extremity business grow single digit full year turn call vice president chief financial today focus comment third quarter financial result relate driver detail financial result provide today press release reminder provide comment comparison normal baseline give variability throughout organic sale growth quarter third quarter include number average sell compare year impact price quarter unfavorable versus price unfavorable foreign currency favorable impact sale business another strong quarter continue growth momentum second quarter double digit growth segment orthopedics spine business adversely impact increase hospitalization rate start early especially result delta variant correspond impact elective procedure significantly slow recovery orthopedics spine implant business quarter organic sale increase reflect continue strong demand instrument medical neurovascular product international organic sale show strong growth impact positive sale momentum emerge market adjust quarterly increase reflect sale growth gross margin expansion lower quarterly effective rate partially offset impact business higher interest charge result acquisition third quarter positively impact foreign currency provide highlight around segment performance orthopaedics constant currency sale growth organic sale growth include organic growth reflect impact slowdown elective procedure result delta variant primarily impact knee implant business knee business grow organically reflect previously mention impact elective procedure offset continue adoption robotic platform total knee procedure trauma business grow reflect solid performance across portfolio ortho grow primarily reflect demand robotic platform partially offset decline bone cement internationally orthopaedics grow organically reflect strong performance momentum internationally somewhat offset increase impact restriction impose elective procedure especially quarter trauma extremity business include writer medical deliver growth comparable basis comparable growth include double digital growth upper extremity business quarter constant currency organic sale growth include organic growth instrument organic sale growth lead double digit growth orthopedic implant surgical technology business include power tool waste management smoke evacuation skin closure product endoscopy organic sale growth reflect strong performance across portfolio include video general surgery product strong double digit growth communication sport medicine business medical division organic growth reflect double digit performance emergency care business internationally organic sale growth reflect strong growth endoscopy instrument medical business across spine organic growth growth reflect double digit performance neurovascular neurosurgical interventional spine business neurovascular business particularly strong growth approximately make roughly segment business post organic growth reflect strong product growth bipolar forceps bone mill neurovascular business significant growth category product include hemorrhagic flow diversion ischemic internationally spine organic growth performance drive strong demand emerge market focus operate highlight third quarter adjust gross margin favorable approximately basis point third quarter compare third quarter gross margin primarily impact acquisition partially offset business price adjust spend sale reflect continue focus innovation sale slightly negative compare third quarter reflect continue discipline leverage offset ramp certain expense hire support future growth dilutive impact medical acquisition summary quarter adjust operate margin sale approximately third quarter performance primarily result positive sale momentum offset dilutive impact acquisition primarily medical relate income expense compare third quarter decline investment income earn deposit interest expense increase relate debt outstanding fund medical acquisition third quarter adjust effective rate impact income favorable discrete item quarter year date effective rate year continue expect adjust effective rate focus balance sheet third quarter billion cash marketable security total debt billion year date billion debt complete refinance revolve credit facility increase facility billion billion turn cash flow year date cash operation approximately billion performance reflect result earn continue focus work capital management base performance third quarter continue volatility experience result procedural delay hospital staff shortage uncertainty around pace recovery fourth quarter expect organic sale growth range relate sale expectation medical expect comparable growth trauma extremity single digit full year compare combine result foreign currency exchange rate hold near current level expect sale full year positively impact approximately adjust earn dilute share positively impact approximately full year include revise guidance range base performance first nine month include consideration aforementioned volatility impact recovery elective procedure full year medical impact expect adjust earn dilute share range open call